1131992-22-7

Basic information

• Product Name: 2,4-Dichloro-7-(phenylsulfonyl)-7H-Pyrrolo[2,3-d]pyrimidine
• Synonyms: 2,4-Dichloro-7-(phenylsulfonyl)-7H-Pyrrolo[2,3-d]pyrimidine;7-(benzenesulfonyl)-2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine
• CAS NO: 1131992-22-7
• Molecular Formula: C₁₂H₇Cl₂N₃O₂S
• Molecular Weight: 328.18
• Mol File: 1131992-22-7.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 438.7±55.0 °C(Predicted)
• Appearance: /
• Density: 1 +-.0.1 g/cm3(Predicted)
• PKA: 0.55±0.30(Predicted)
• CAS DataBase Reference: 2,4-Dichloro-7-(phenylsulfonyl)-7H-Pyrrolo[2,3-d]pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-Dichloro-7-(phenylsulfonyl)-7H-Pyrrolo[2,3-d]pyrimidine(1131992-22-7)
• EPA Substance Registry System: 2,4-Dichloro-7-(phenylsulfonyl)-7H-Pyrrolo[2,3-d]pyrimidine(1131992-22-7)

Safety Data

• Hazardous Substances Data: 1131992-22-7(Hazardous Substances Data)

Usage

General Description

2,4-Dichloro-7-(phenylsulfonyl)-7H-Pyrrolo[2,3-d]pyrimidine is a chemical compound with the molecular formula C15H8Cl2N2O2S. It is a pyrrolopyrimidine derivative that contains two chlorine atoms and a phenylsulfonyl group. 2,4-Dichloro-7-(phenylsulfonyl)-7H-Pyrrolo[2,3-d]pyrimidine has been studied for its potential use as a pharmaceutical agent, particularly in the field of medicinal chemistry. Its structure and properties make it a promising candidate for further research and development as a potential therapeutic agent for various medical applications.

Upstream product

• 90213-66-4 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine 
• 98-09-9 benzenesulfonyl chloride 

Downstream Products

• 1131992-26-1 7-benzenesulfonyl-6-bromo-2,4-dichIoro-7H-pyrrolo[2,3-d]pyrimidine 
• 1131992-30-7 6-bromo-2,4-dichloro-7H-pyrroIo[2,3-d]pyrimidine 
• 1638768-44-1 C₁₃H₇Cl₂N₃O₄S 

Relevant articles and documents

Heterocyclic Adenosine Receptor Antagonists

Heterocyclic compounds useful as antagonists of adenosine receptors, and methods of treatment of diseases using antagonists of adenosine receptors are disclosed herein. Also disclosed herein are pharmaceutical compositions and methods of administration of

Key intermediate for synthesis of CDK 4/6 dual inhibitor and preparation method and application of key intermediate

The invention discloses a 2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-methanamide intermediate and a preparation method and application thereof. The intermediate is the compoundI, and the preparation method comprises the following st

PYRROLOPYRIMIDINE COMPOUNDS

Compounds of formula (I) are A2B receptor antagonists: wherein Ri is optionally substituted aryl or an optionally substituted monocyclic heteroaryl group having 5 or 6 ring atoms; R2 and R3 are independently selected from